STANDARD CHEMICAL & PHARMACEUTICAL CO. LTD.

Standard Chemical & Pharmaceutical Co. Ltd.

1720

TW0001720001

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 25/06/2024 am IST			5-day change	1st Jan Change
73.8 ^TWD	-0.14%		+3.22%	+11.99%

08/05	Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/03	Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Standard Chem & Pharm Co., Ltd. Announces Establishment of Audit Committee with Independent Directors Hwei-Jiung, Wang; Shaw-Tzong, Liu; and Lin-Yu, Lee as Members with Effect from August 24, 2021

August 24, 2021 at 05:38 pm IST

Standard Chem & Pharm CO., LTD. announced establishment of audit committee with effect from August 24, 2021. The independent directors Hwei-Jiung, Wang; Shaw-Tzong, Liu; and Lin-Yu, Lee were appointed as members of the committee.

Latest news about Standard Chemical & Pharmaceutical Co. Ltd.

Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03	CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces Cash Dividend, Payable on August 31, 2023	07/23/07	CI
Standard Chemical & Pharmaceutical Co. Ltd. Appoints Lawrence C. Lee, Independent Director as Audit Committee Member, Effective June 20, 2023	20/23/20	CI
Standard Chemical & Pharmaceutical Co. Ltd. Elects One Additional Director and One Additional Independent Director	20/23/20	CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10	CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces Executive Changes	14/23/14	CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces CFO Changes	14/23/14	CI
Standard Chemical & Pharmaceutical Co. Ltd. Receives Resignation Letter from Chin-Tsai, Fan, the Chairman of the Board, Effective March 14, 2023	06/23/06	CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04/22/04	CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	03/22/03	CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022	11/22/11	CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2021	17/22/17	CI
Standard Chem & Pharm Co., Ltd. Announces Establishment of Audit Committee with Independent Directors Hwei-Jiung, Wang; Shaw-Tzong, Liu; and Lin-Yu, Lee as Members with Effect from August 24, 2021	24/21/24	CI
Standard Chem & Pharm Co., Ltd. Replaces Mei-Ju, Shen with Shaw-Tzong, Liu as Member of the Remuneration Committee with Effect from August 24, 2021	24/21/24	CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the Second Quarter Ended June 30, 2021	04/21/04	CI
Standard Chem & Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	04/21/04	CI
Standard Chem & Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	17/21/17	CI
SYN-TECH Chem. & Pharm. Co., Ltd. agreed to acquire API synthesis department of Standard Chemical from Standard Chem & Pharm CO., LTD. for TWD 341 million.	16/21/16	CI
Standard Chem & Pharm Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	03/20/03	CI
Standard Chem & Pharm Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	05/20/05	CI
Standard Chem & Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	05/20/05	CI

Chart Standard Chemical & Pharmaceutical Co. Ltd.

Duration

Period

Chart Standard Chemical & Pharmaceutical Co. Ltd.

More charts

Company Profile

Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Companyâs products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

73.8 TWD

Average target price

80 TWD

Spread / Average Target

+8.40%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
STANDARD CHEMICAL & PHARMACEUTICAL CO. LTD.	+11.99%	405M
ELI LILLY AND COMPANY	+55.19%	815B
NOVO NORDISK A/S	+47.26%	654B
JOHNSON & JOHNSON	-6.09%	354B
MERCK & CO., INC.	+21.92%	337B
ASTRAZENECA PLC	+18.40%	247B
ROCHE HOLDING AG	+3.64%	229B
NOVARTIS AG	+12.98%	219B
AMGEN INC.	+10.86%	171B
PFIZER, INC.	-2.78%	159B

Other Pharmaceuticals

Standard Chemical & Pharmaceutical Co. Ltd.

Equities

1720

TW0001720001

Pharmaceuticals

Standard Chem & Pharm Co., Ltd. Announces Establishment of Audit Committee with Independent Directors Hwei-Jiung, Wang; Shaw-Tzong, Liu; and Lin-Yu, Lee as Members with Effect from August 24, 2021

Latest news about Standard Chemical & Pharmaceutical Co. Ltd.

Chart Standard Chemical & Pharmaceutical Co. Ltd.

Company Profile

Income Statement Evolution

Analysts' Consensus

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals